Skip nav

R&D Projects

Confirmed projects database queries

The information may be unavailable due to the results not being approved or confirmed. In particular, when a call includes regions where projects are cofunded by EC funds and others where that is not the case, confirmation or approval may be not simultaneous.

Call for Proposals for Scientific Research and Technological Development Projects in all Scientific Domains - 2010

Health Sciences - Pharmaceutical sciences

    Painel de Avaliação da área das Ciências da Saúde - 2010
  • Robert Hofstra
  • Christoph Tang
  • E.M. Hol
  • Louis Lemieux
  • Jean-Michel Bouler
  • Luca Mainardi
  • Maurice Zeegers
  • Francisco Bolumar
  • Stephen Paul Hilary Alexander
  • Jochen Klein
  • Ad Geurts van Kessel
  • Fernando Giraldez Orgaz
  • Humphrey Hodgson
  • Geert Martens
  • Gerard J te Meerman
  • Maxime GUYE
  • Bruno Bujoli
  • Andrew Westwell
  • Stephen Hiscox
  • Marc Bracke
  • Roberto Sassi
  • Anna Maria Bianchi
  • Raymond Macallister
  • Herman Waldmann
  • Carlos Fitzsimons
  • Willem Kamphuis
  • Martin Prins
  • Dagmar Fischer
  • Miguel Delgado
  • Lionel Ginsberg
  • Derek Macallan

Non-invasive-Non-viral Silencing of Machado-Joseph disease. LUÍS FERNANDO MORGADO PEREIRA DE ALMEIDA, Centro de Neurociências e Biologia Celular (CNBC/UC). €108,280.


Towards malaria eradication. A novel approach for multi-targeting the parasite´s life cycle. Francisca Lopes, Faculdade de Farmácia da Universidade de Lisboa (FF/ULisboa). €132,014.


ARE MICROGLIA A NEW POTENTIAL PHARMACOLOGICAL TARGET IN AMYOTROPHIC LATERAL SCLEROSIS (ALS)? Dora Brites, Faculdade de Farmácia da Universidade de Lisboa (FF/ULisboa). €146,273.


ArmAb: New strategy of ADC for arming antibodies in cancer therapy. Joao Goncalves, Associação para o Desenvolvimento do Ensino e Investigação da Microbiologia (ADEIM). €99,189.


TherMelVac- dendritic cell-targeted peptide vaccine against melanoma by ligand-modified nanoparticles. Helena Isabel Fialho Florindo Roque Ferreira, Faculdade de Farmácia da Universidade de Lisboa (FF/ULisboa). €126,649.


siRNA incorporation in a lipid/micelle-based nanocarrier as a strategy to restore E-cadherin expression and eradicate advanced breast cancer metastatic phenotype. Mafalda de Castro Ascensão Marques Videira, Faculdade de Farmácia da Universidade de Lisboa (FF/ULisboa). €115,809.


Neuropeptide release in wounds: a new therapeutic approach for the treatment of diabetic foot ulceration. Ermelindo Carreira Leal, Centro de Neurociências e Biologia Celular (CNBC/UC). €128,405.